Leavell Investment Management’s Charles River Laboratories CRL Stock Holding History

Leavell Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$863K	Buy	3,804 +778	+26%	+$139K	0.03%	345
2026 Q1	$522K	Buy	3,026 +8	+0.3%	+$1.48K	0.02%	410
2025 Q4	$602K	Hold	3,018	–	–	0.03%	377
2025 Q3	$472K	Hold	3,018	–	–	0.02%	420
2025 Q2	$458K	Hold	3,018	–	–	0.02%	422
2025 Q1	$454K	Sell	3,018 -1,003	-25%	-$168K	0.02%	403
2024 Q4	$742K	Hold	4,021	–	–	0.04%	317
2024 Q3	$792K	Sell	4,021 -11	-0.3%	-$2.29K	0.04%	321
2024 Q2	$833K	Buy	4,032 +32	+0.8%	+$7.25K	0.05%	291
2024 Q1	$1.08M	Sell	4,000 -600	-13%	-$143K	0.06%	256
2023 Q4	$1.09M	Hold	4,600	–	–	0.07%	245
2023 Q3	$902K	Hold	4,600	–	–	0.06%	261
2023 Q2	$967K	Hold	4,600	–	–	0.07%	254
2023 Q1	$928K	Hold	4,600	–	–	0.07%	252
2022 Q4	$1M	Buy	4,600 +100	+2%	+$21.8K	0.08%	232
2022 Q3	$886K	Hold	4,500	–	–	0.07%	237
2022 Q2	$963K	Hold	4,500	–	–	0.07%	230
2022 Q1	$1.28M	Hold	4,500	–	–	0.09%	205
2021 Q4	$1.7M	Hold	4,500	–	–	0.11%	171
2021 Q3	$1.86M	Sell	4,500 -300	-6%	-$125K	0.14%	150
2021 Q2	$1.39M	Hold	4,800	–	–	0.11%	171
2021 Q1	$1.39M	Hold	4,800	–	–	0.11%	171
2020 Q4	$1.2M	Hold	4,800	–	–	0.1%	176
2020 Q3	$1.09M	Hold	4,800	–	–	0.09%	176
2020 Q2	$837K	Hold	4,800	–	–	0.08%	192
2020 Q1	$606K	Hold	4,800	–	–	0.07%	204
2019 Q4	$733K	Hold	4,800	–	–	0.07%	220
2019 Q3	$635K	Hold	4,800	–	–	0.07%	232
2019 Q2	$681K	Hold	4,800	–	–	0.07%	228
2019 Q1	$697K	Hold	4,800	–	–	0.08%	217
2018 Q4	$543K	Hold	4,800	–	–	0.07%	232
2018 Q3	$646K	Hold	4,800	–	–	0.07%	230
2018 Q2	$539K	Hold	4,800	–	–	0.06%	243
2018 Q1	$512K	Hold	4,800	–	–	0.06%	251
2017 Q4	$525K	Hold	4,800	–	–	0.06%	250
2017 Q3	$518K	Hold	4,800	–	–	0.06%	245
2017 Q2	$486K	Buy	4,800 +300	+7%	+$27.6K	0.06%	254
2017 Q1	$405K	Hold	4,500	–	–	0.05%	267
2016 Q4	$343K	Hold	4,500	–	–	0.05%	283
2016 Q3	$375K	Hold	4,500	–	–	0.06%	275
2016 Q2	$371K	Hold	4,500	–	–	0.05%	280
2016 Q1	$342K	Hold	4,500	–	–	0.05%	280
2015 Q4	$362K	Hold	4,500	–	–	0.05%	272
2015 Q3	$286K	Hold	4,500	–	–	0.05%	315
2015 Q2	$317K	Hold	4,500	–	–	0.05%	317
2015 Q1	$357K	Hold	4,500	–	–	0.05%	301
2014 Q4	$286K	Buy	4,500 +500	+13%	+$31.3K	0.04%	332
2014 Q3	$239K	Hold	4,000	–	–	0.04%	347
2014 Q2	$214K	Hold	4,000	–	–	0.03%	382
2014 Q1	$241K	Hold	4,000	–	–	0.04%	351
2013 Q4	$212K	Buy	+4,000	New	+$201K	0.04%	370

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Leavell Investment Management's CRL Position: Q2 2026 in Review

Leavell Investment Management increased its Charles River Laboratories (CRL) stake by 26% in Q2 2026, buying an estimated $139K and bringing the position to 3,804 shares worth $863K. The position accounts for 0.03% of the portfolio, ranked #345.

Leavell Investment Management first reported a position in CRL in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.86M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Leavell Investment Management held 3,804 shares of Charles River Laboratories worth $863K as of Q2 2026.
Leavell Investment Management bought 778 Charles River Laboratories shares in Q2 2026, an estimated $139K.
Charles River Laboratories made up 0.03% of Leavell Investment Management's portfolio in Q2 2026, its #345 holding.
Leavell Investment Management first reported a position in Charles River Laboratories in Q4 2013 and has held it in 51 quarters since.
Leavell Investment Management's Charles River Laboratories position peaked at $1.86M in Q3 2021.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.